Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT03298698Phase 3Unknown
Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome
Focal Segmental GlomerulosclerosisIdiopathic Nephrotic SyndromeMinimal Change Disease
StudychairStart date: 2018-08-22

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Radboud University Nijmegen Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeroen K Deegens, MD,PhD

Radboud University Nijmegen Medical center

Moderately Similar
1 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalIdiopathic Nephrotic SyndromeNephrosis, Lipoid

Worked with same sponsors:

Radboud University Medical Center
Collaborated on 1 trial
Similarity Score34%

Eloise Salmon, M.D.

University of Michigan

Related
1 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Matthias Kretzler, MD

University of Michigan

Related
3 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Radko Komers, MD, PhD

Travere Therapeutics, Inc.

Related
4 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Keenan

ValenzaBio, Inc.

Related
2 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

William A Gahl, M.D.

National Human Genome Research Institute (NHGRI)

Related
12 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Dong Ki Kim, MD, PhD

Seoul National University Hospital

Related
3 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Safak Mirioglu, MD

Department of Internal Medicine, Istanbul Faculty of Medicine

Related
4 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Halil Yazici, MD

Department of Internal Medicine, Istanbul Faculty of Medicine

Related
4 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalNephrosis, Lipoid
Similarity Score20%

Jeffrey B Kopp, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
7 trials

Shared therapeutic areas:

Glomerulosclerosis, Focal SegmentalIdiopathic Nephrotic Syndrome
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03298698Phase 3StudyChair

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome

Focal Segmental GlomerulosclerosisIdiopathic Nephrotic SyndromeMinimal Change Disease
Unknown

All 1 trials loaded